AIM ImmunoTech (AIM) Financial Statements & Analysis

AIM ImmunoTech (AIM) Income Statement

AIM ImmunoTech reported revenue of $88.00K in fiscal 2025 (fiscal year ended Mar 31, 2026), down 48.2% from $170.00K a year earlier. AIM ImmunoTech posted a net loss of $13.96M, compared with a net loss of $17.32M a year earlier. Gross margin was -284.1% and operating margin -11961.4%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $26.00K, up 4.0% from the same quarter a year earlier.

AIM ImmunoTech Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

AIM ImmunoTech Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Mar 2023	Dec 2022	Mar 2022	Dec 2021	Mar 2021	Mar 2020	Mar 2019	Dec 2017
Revenue & Gross Profit
Revenue	0.09	0.09	0.17	0.20	0.20	0.14	0.14	0.14	0.14	0.16	0.14	0.37	0.44
Cost of Revenue	0.34	0.13	0.03	0.04	0.04	0.00	-	0.85	0.85	0.81	0.89	0.88	1.18
Gross Profit	-0.25	-0.04	0.14	0.16	0.16	0.14	0.14	-0.72	-0.72	-0.64	-0.75	-0.52	-0.75
Operating Expenses
Research & Development	3.92	3.55	6.20	10.93	10.94	6.99	6.77	7.67	7.67	5.72	4.65	4.78	4.10
Selling, General & Administrative	7.70	8.07	13.71	21.14	21.14	13.07	13.29	8.67	8.67	8.65	7.04	6.20	6.57
Operating Expenses	10.28	11.62	19.91	32.08	32.08	20.06	20.06	18.12	18.12	14.51	11.69	10.98	10.67
Operating Income	-10.53	-11.66	-19.77	-31.92	-31.92	-19.92	-19.92	-18.84	-18.84	-15.15	-12.44	-11.50	-11.42
Other Income/Expense
Interest Income	3.18	3.18	5.19	1.07	1.07	0.63	0.63	0.00	-	0.22	0.09	0.03	0.09
Interest Expense	0.81	0.81	0.59	0.00	-	0.00	-	0.07	-	0.67	0.43	0.50	0.14
Other Income/Expense	-3.43	-2.29	2.45	2.95	1.89	0.48	0.48	-0.29	-0.29	0.75	3.04	1.67	3.16
Income
Income Before Tax	-13.96	-13.96	-17.32	-28.96	-28.96	-19.45	-19.45	-19.13	-19.13	-14.40	-9.40	-9.81	-8.26
Income Tax Expense	0.00	-	0.00	0.00	-	0.00	-	0.00	-	0.00	0.00	2.19	0.00
Net Income	-13.96	-13.96	-17.32	-28.96	-28.96	-19.45	-19.45	-19.13	-19.13	-14.40	-9.40	-9.81	-8.26
Net Income - Continuous Operations	-13.96	-13.96	-17.32	-28.96	-28.96	-19.45	-19.45	-19.13	-	-14.40	-9.40	-9.81	-8.26
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-12.94	-11.45	-16.49	-28.72	-28.72	-19.19	-19.67	-18.29	-16.28	-13.00	-8.15	-8.41	-7.12
EBIT	-	-11.66	-16.74	-	-28.96	-	-19.92	-	-17.06	-	-	-	-
Depreciation & Amortization	0.21	0.21	0.25	0.24	0.24	0.26	0.26	0.78	-	0.73	0.83	0.92	1.00
Earnings Per Share
Basic EPS	-9.00	-9.00	-11.00	-22.00	-60.00	-15.00	-40.00	-15.00	-40.00	-16.00	-94.00	-355.00	-463.00
Diluted EPS	-9.00	-9.00	-11.00	-22.00	-60.00	-15.00	-40.00	-15.00	-40.00	-16.00	-94.00	-355.00	-463.00
Basic Shares Outstanding	1.62	1.62	1.54	1.34	0.49	1.33	0.48	1.31	0.47	0.88	0.10	0.03	0.02
Diluted Shares Outstanding	1.62	1.62	1.54	1.34	0.49	1.33	0.48	1.31	0.47	0.88	0.10	0.03	0.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AIM ImmunoTech Financial Statements

What was AIM ImmunoTech's revenue in fiscal 2025?

AIM ImmunoTech reported revenue of $88.00K in fiscal 2025 (fiscal year ended Mar 31, 2026). That was down 48.2% from $170.00K a year earlier.

Is AIM ImmunoTech profitable?

No. AIM ImmunoTech reported a net loss of $13.96M in fiscal 2025. In fiscal 2024 it lost $17.32M.

What is AIM ImmunoTech's operating margin?

AIM ImmunoTech's operating income was −$10.53M on revenue of $88.00K in fiscal 2025, an operating margin of -11961.4%, compared with -11630.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition